Back
Xeris Biopharma Holdings Vs. Phathom Pharmaceuticals Industry Stock Comparison
Buy
89
XERS
Xeris Biopharma Holdings
Last Price:
2.03
Seasonality Move:
-12.45%
Buy
78
PHAT
Phathom Pharmaceuticals
Last Price:
10.71
Seasonality Move:
-9.38%
Buy
89
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
- The current Xeris Biopharma Holdings [XERS] share price is $1.98. The Score for XERS is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- XERS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
78
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $10.41. The Score for PHAT is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $1.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight buying pressure.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $10.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing slight buying pressure.
XERS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 56.2 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.75 - 1.91) | Buy |
| Bollinger Bands (100): | (1.89 - 2.77) | Sell |
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 56.38 | Buy |
| Chaikin Money Flow: | 23052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.19 - 10.27) | Buy |
| Bollinger Bands (100): | (7.63 - 10.43) | Buy |
XERS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.88 | Buy |
| 20-day SMA: | 1.81 | Buy |
| 50-day SMA: | 1.99 | Sell |
| 200-day SMA: | 2.15 | Sell |
| 8-day EMA: | 1.88 | Buy |
| 20-day EMA: | 1.87 | Buy |
| 50-day EMA: | 2.02 | Sell |
| 200-day EMA: | 2.16 | Sell |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.16 | Buy |
| 20-day SMA: | 9.63 | Buy |
| 50-day SMA: | 9.75 | Buy |
| 200-day SMA: | 9.86 | Buy |
| 8-day EMA: | 10.06 | Buy |
| 20-day EMA: | 9.91 | Buy |
| 50-day EMA: | 9.69 | Buy |
| 200-day EMA: | 9.74 | Buy |
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.04 per share, an increase this year of $0.01 per share, and an increase next year of $0.20 per share.
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.34 per share, a decrease this year of $1.15 per share, and an increase next year of $1.18 per share.
Xeris Biopharma Holdings Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Phathom Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||